Angiogenesis induced by acidic fibroblast growth factor as an alternative method of revascularization for chronic myocardial ischemia.

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Surgery

• Publication date

  1996-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0039-6060(96)80286-8PMID 8751581
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Vascular endothelial growth factor administration in chronic myocardial ischemia.

  1996cited by this paper
• Angiotensin-converting enzyme inhibition preserves endothelium-dependent coronary microvascular responses during short-term ischemia-reperfusion.

  1996cited by this paper
• Enhanced microvascular relaxations to VEGF and bFGF in chronically ischemic porcine myocardium.

  1996cited by this paper
• Magnetic resonance mapping demonstrates benefits of VEGF–induced myocardial angiogenesis

  1995cited by this paper
• Beta-adrenergic modulation of the collateral-dependent coronary microcirculation.

  1995cited by this paper
• Therapeutic angiogenesis. A single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model.

  1994cited by this paper
• Angiogenic-induced enhancement of collateral blood flow to ischemic myocardium by vascular endothelial growth factor in dogs.

  1994cited by this paper
• Contrasting Effects of the Intermittent and Continuous Administration of Heparin in Experimental Restenosis

  1994cited by this paper
• Basic fibroblast growth factor improves myocardial function in chronically ischemic porcine hearts.

  1994cited by this paper
• Basic FGF enhances endothelium-dependent relaxation of the collateral-perfused coronary microcirculation.

  1994cited by this paper
• Vascular endothelial growth factor induces EDRF-dependent relaxation in coronary arteries.

  1993cited by this paper
• Recombinant fibroblast growth factor-1 promotes intimal hyperplasia and angiogenesis in arteries in vivo

  1993cited by this paper
• Endothelial modulation of porcine coronary microcirculation perfused via immature collaterals.

  1992cited by this paper
• Conversion of cysteine to serine residues alters the activity, stability, and heparin dependence of acidic fibroblast growth factor.

  1991cited by this paper
• Measurement of Regional Myocardial Blood Flow With Multiple Colored Microspheres*

  1991cited by this paper
• Hypotensive activity of fibroblast growth factor.

  1991cited by this paper
• Ischemia-reperfusion impairs endothelium-dependent relaxation of coronary microvessels but does not affect large arteries.

  1990cited by this paper
• Effect of controlled adventitial heparin delivery on smooth muscle cell proliferation following endothelial injury.

  1990cited by this paper
• Endothelial modulation of the coronary vasculature in vessels perfused via mature collaterals.

  1990cited by this paper
• Vasomotor activity of moderately well-developed canine coronary collateral circulation.

  1989cited by this paper
• Vasopressin and the mature coronary collateral circulation.

  1989cited by this paper
• Enhanced release of endothelium-derived factor(s) by chronic increases in blood flow.

  1988cited by this paper
• Development of coronary collateral circulation in left circumflex Ameroid-occluded swine myocardium.

  1987cited by this paper
• Absence of Functioning α‐Adrenergic Receptors in Mature Canine Coronary Collaterals

  1986cited by this paper
• Cardiac transplantation in perspective for the future. Survival, complications, rehabilitation, and cost.

  1982cited by this paper
• Coronary vascular reactivity after acute myocardial ischemia.

  1982cited by this paper

• Coronary Microvascular Adaptations Distal to Epicardial Artery Stenosis.

  2021cites this paper
• Regulatory Role of Endogenous and Exogenous Fibroblast Growth Factor 1 in the Cardiovascular System and Related Disease.

  2021cites this paper
• Mechanobiology of Microvascular Function and Structure in Health and Disease: Focus on the Coronary Circulation

  2021cites this paper
• The Active Compounds of Yixin Ningshen Tablet and Their Potential Action Mechanism in Treating Coronary Heart Disease- A Network Pharmacology and Proteomics Approach

  2020cites this paper
• HS3ST1 genotype regulates antithrombin's inflammomodulatory tone and associates with atherosclerosis.

  2017cites this paper
• Stimulation of angiogenesis through growth factor delivery from synthetic heparinised hydrogels

  2017cites this paper
• SPECT and PET imaging of angiogenesis and arteriogenesis in pre-clinical models of myocardial ischemia and peripheral vascular disease

  2016cites this paper
• porcine model of chronic myocardial ischemia Angiogenic potential of perivascularly delivered aFGF in a

  2016cites this paper
• Therapeutic angiogenesis using tumor cell‐conditioned medium

  2016cites this paper
• Therapeutic site selection is important for the successful development of collateral vessels.

  2015cites this paper
• Potential matrix metalloproteinase inhibitors from edible marine algae: a review.

  2014cites this paper
• Fucoidans from marine algae as potential matrix metalloproteinase inhibitors.

  2014cites this paper
• Genistein Promotes Endothelial Colony-Forming Cell (ECFC) Bioactivities and Cardiac Regeneration in Myocardial Infarction

  2014cites this paper
• Phase II angiogenesis stimulators

  2013cites this paper
• Beneficial Effects of Marine Algal Compounds in Cosmeceuticals

  2013cites this paper
• Angiogenic therapy for cardiac repair based on protein delivery systems

  2012cites this paper
• Coronary collateral growth--back to the future.

  2012cites this paper
• Transgenic Expression of Nonclassically Secreted FGF Suppresses Kidney Repair

  2012cites this paper
• Phlorotannins and fucoidans from marine macroalgae as matrix metalloproteinase inhibitory substances and their possible application as medicinal foods.

  2011cites this paper
• Acceleration of diabetic‐wound healing with PEGylated rhaFGF in healing‐impaired streptozocin diabetic rats

  2011cites this paper
• Growth factor loaded-microparticles as a tool for cardiac repair

  2011cites this paper
• Les Signaux Post Mortem (SPM) de l’apoptose endothéliale : des acteurs du remodelage vasculaire

  2011cites this paper
• Altered coronary microvascular serotonin receptor expression after coronary artery bypass grafting utilizing cardiopulmonary bypass

  2010cites this paper
• Altered coronary microvascular serotonin receptor expression after coronary artery bypass grafting with cardiopulmonary bypass.

  2010cites this paper
• Stromal Cell-Derived Factor-1 (cid:1) Activation of Tissue-Engineered Endothelial Progenitor Cell Matrix Enhances Ventricular Function After Myocardial Infarction by Inducing Neovasculogenesis

  2010cites this paper
• Stromal Cell-Derived Factor-1&agr; Activation of Tissue-Engineered Endothelial Progenitor Cell Matrix Enhances Ventricular Function After Myocardial Infarction by Inducing Neovasculogenesis

  2010cites this paper
• Endostatin and angiostatin are increased in diabetic patients with coronary artery disease and associated with impaired coronary collateral formation.

  2009cites this paper
• TP508 (Chrysalin®) Reverses Endothelial Dysfunction and Increases Perfusion and Myocardial Function in Hearts With Chronic Ischemia

  2008cites this paper
• Secretion without Golgi

  2008cites this paper
• Novel cross-talk between three cardiovascular regulators: thrombin cleavage fragment of Jagged1 induces fibroblast growth factor 1 expression and release.

  2008cites this paper
• Construction and characterization of a thrombin-resistant designer FGF-based collagen binding domain angiogen.

  2008cites this paper
• Angiogenesis, haemostasis and cancer: new paradigms and old concerns

  2007cites this paper
• Digital Comprehensive Summaries of Uppsala Dissertations from the Faculty of Medicine 142 Effect of Hyaluronan-activation of CD 44 on Cell Signaling and Tumorigenesis

  2006cites this paper
• Pharmaceutical interventions to influence arteriogenesis: new concepts to treat ischemic heart disease.

  2006cites this paper
• Effect of Hyaluronan-activation of CD44 on Cell Signaling and Tumorigenesis

  2006cites this paper
• Angiogenesis "in vitro" of the healthy mouse heart under hypoxia : the role of Angiotensin II and Nitric Oxide

  2005cites this paper
• Therapeutic Angiogenesis for the Treatment of Coronary Artery Disease : Can We Improve the Results?

  2005cites this paper
• Protective effects of non-mitogenic human acidic fibroblast growth factor on hydrogen peroxide-induced damage to cardiomyocytes in vitro.

  2005cites this paper
• Therapeutische Angiogenese bei chronischer Myokardischämie - Applikation von FGF-2 mittels selektiver druckregulierter Retroinfusion im tierexperimentellen Modell am Schwein

  2004cites this paper
• A versatile in vitro assay for investigating angiogenesis of the heart.

  2004cites this paper
• Protein-, gene-, and cell-based therapeutic angiogenesis for the treatment of myocardial ischemia

  2004cites this paper
• Therapeutische Angiogenese bei chronischer Myokardischämie - Applikation von FGF-2 mittels selektiver druckregulierter Retroinfusion im tierexperimentellen Modell am Schwein

  2004cites this paper
• Monocyte Chemoattractant Protein 1-Induced Monocyte Infiltration Produces Angiogenesis but Not Arteriogenesis in Chronically Infarcted Myocardium

  2004cites this paper
• Altered calcium sensitivity contributes to enhanced contractility of collateral-dependent coronary arteries.

  2004cites this paper
• Role of single photon emission computed tomography imaging in the evaluation of therapy for angina pectoris.

  2003cites this paper
• Angiogenic protein therapy.

  2003cites this paper
• Angiogenesis of the heart

  2003cites this paper
• Enhanced hindlimb collateralization induced by acidic fibroblast growth factor is dependent upon femoral artery extraction.

  2003cites this paper
• Low-Molecular-Weight Fucoidan Promotes Therapeutic Revascularization in a Rat Model of Critical Hindlimb Ischemia

  2003cites this paper
• Gene-based therapeutic angiogenesis.

  2003cites this paper
• Tissue engineering strategies for in vivo neovascularisation

  2002cites this paper
• Therapeutic Angiogenesis for the Treatment of Cardiovascular Disease

  2002cites this paper
• Therapeutic Angiogenesis for the Heart

  2002cites this paper
• Proliferación vascular inducida por genes

  2001cites this paper
• Efficacy of intracoronary or intravenous VEGF165 in a pig model of chronic myocardial ischemia.

  2001cites this paper
• Angiogenesis and the ischaemic heart.

  2001cites this paper
• Sarcoplasmic reticulum Ca(2+) uptake is impaired in coronary smooth muscle distal to coronary occlusion.

  2001cites this paper
• Gene therapy for therapeutic angiogenesis in critically ischaemic lower limb – on the way to the clinic

  2001cites this paper
• Therapeutic coronary angiogenesis: a fronte praecipitium a tergo lupi?

  2001cites this paper
• Induktion der myokardialen Neoangiogenese durch humane Wachstumsfaktoren Ein neuer Therapieansatz bei koronarer Herzkrankheit

  2000cites this paper
• Gentherapie bei kardiovaskulären Erkrankungen

  2000influential citation
• Exercise training restores adenosine-induced relaxation in coronary arteries distal to chronic occlusion.

  2000cites this paper
• [Induction of myocardial neoangiogenesis by human growth factors. A new therapeutic approach in coronary heart disease].

  2000cites this paper
• Klinische Ergebnisse der Behandlung der koronaren Herzkrankheit mit Wachstumsfaktoren

  2000cites this paper
• Myocardial ischemia enhances the expression of acidic fibroblast growth factor in human pericardial fluid

  2000cites this paper
• Focal angiogen therapy using intramyocardial delivery of an adenovirus vector coding for vascular endothelial growth factor 121.

  2000cites this paper
• PR39, a peptide regulator of angiogenesis

  2000cites this paper
• Transmyocardial laser revascularization and angiogenesis: the potential for therapeutic benefit.

  1999cites this paper
• Intracoronary and intravenous administration of basic fibroblast growth factor: myocardial and tissue distribution.

  1999cites this paper
• New approaches to coronary heart disease: induction of neovascularisation by growth factors.

  1999cites this paper
• Multifactorial basis for coronary collateralization: a complex adaptive response to ischemia.

  1999cites this paper
• Epicardial gene therapy and laser revascularization

  1999cites this paper
• New Approaches to Coronary Heart Disease

  1999cites this paper
• Cardiac angiogenesis and gene therapy: a strategy for myocardial revascularization.

  1999cites this paper
• Safety of Direct Myocardial Administration of an Adenovirus Vector Encoding Vascular Endothelial Growth Factor 121

  1999cites this paper
• Therapeutic Angiogenesis: Protein and Gene Therapy Delivery Strategies

  1999cites this paper
• Angiogenesis in cardiovascular disease: current status and therapeutic potential.

  1999cites this paper
• Angiogenesis in Cardiovascular Disease

  1999cites this paper
• Therapeutic Coronary Angiogenesis

  1999cites this paper
• Myocardial Ischemia and Growth Factor Therapy

  1999cites this paper
• Myocardial Angiogenesis: Biology and Therapy

  1999cites this paper
• Angiogenic potential of perivascularly delivered aFGF in a porcine model of chronic myocardial ischemia.

  1998cites this paper
• Gene therapy for myocardial angiogenesis: initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia.

  1998cites this paper
• Therapeutic angiogenesis.

  1998cites this paper
• New Trends in Coronary Revascularization: Neoangiogenesis by Human Growth Factors

  1998cites this paper
• The application of individualised fetal growth curves.

  1998cites this paper
• Coronary blood flow in fetuses with intrauterine growth restriction.

  1998cites this paper
• The application of individualised fetal growth curves.

  1998cites this paper
• Therapeutic angiogenesis with basic fibroblast growth factor: technique and early results.

  1998cites this paper
• Angiogenesis and Vasculogenesis in Treatment of Cardiovascular Disease

  1998cites this paper
• FGF-1: a human growth factor in the induction of neoangiogenesis.

  1998cites this paper
• Modulation of myocardial perfusion and vascular reactivity by pericardial basic fibroblast growth factor: insight into ischemia-induced reduction in endothelium-dependent vasodilatation.

  1998cites this paper
• Myocardial Angiogenesis as a Possible Mechanism for TMLR Efficacy

  1997cites this paper
• Arterial gene transfer of acidic fibroblast growth factor for therapeutic angiogenesis in vivo: critical role of secretion signal in use of naked DNA.

  1997cites this paper
• Manipulating angiogenesis. From basic science to the bedside.

  1997cites this paper